SHC
SOTERA HEALTH (SHC)
NASDAQ
$15.77+$0.20 (+1.30%)
Price as of Jun 05, 2026 7:37 AM EDT
  • $4.5B
    Market Cap
  • 27.73%
    1-Year Change
  • Diagnostics & Research
    Industry

Key Performance

More
  • Earnings Score: 38
  • Momentum Score: 53
  • True Yield: N/A
  • Financial Health Score: 70
TradeSmith Loading

Latest Research & News

A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock Drop

Sessa Capital invested $175.8 million in Sotera Health by purchasing 10.6 million shares in Q4, bringing its total stake to 20.55 million shares valued at $362.5 million. Despite a 21% stock decline, the investment signals confidence in the company's fundamentals, which include $1.2 billion in revenue and steady 20-year growth, though the stock faces headwinds from litigation risks, high leverage, and a recent secondary offering that flooded the market with shares.

03/23/2026, 12:19 PM • The Motley Fool

Sotera Health Appoints Kenneth D. Krause to the Board of Directors

Sotera Health Company announced the appointment of Kenneth D. Krause, Executive Vice President and CFO of Rollins, Inc., as a new independent director to its Board of Directors. Krause brings over 10 years of public company CFO experience and expertise in corporate strategy and capital allocation. Simultaneously, Constantine S. Mihas resigned from the Board effective March 16, 2026, due to a reduction in stockholder-designated director positions.

03/16/2026, 7:00 AM • GlobeNewswire

Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals

MIG Capital sold $37.41 million worth of Sotera Health shares (2.26 million shares) in Q4 2025, reducing its stake to 5.88% of AUM. Despite the trim, the fund maintains a significant position in the sterilization and lab testing company. Sotera posted its 20th consecutive year of revenue growth with 5.7% sales increase to $1.16 billion in 2025, while net income nearly doubled to $78 million. The company projects 5-6.5% revenue growth for 2026.

03/15/2026, 10:30 AM • The Motley Fool

Sotera Health Announces Secondary Offering of Common Stock

Sotera Health Company announced a secondary offering of 25 million shares of common stock being sold by affiliates of Warburg Pincus and GTCR. The company will not receive proceeds from the offering but will cover offering expenses. Wells Fargo Securities is acting as the underwriter.

03/04/2026, 4:51 PM • GlobeNewswire

Irenic Dumps Most Papa John's Shares

Irenic Capital Management LP significantly reduced its Papa John's International position by approximately 70%, selling 748,592 shares in Q4 and retaining only 325,108 shares valued at $12.5 million. The stake now represents just 0.8% of the fund's AUM, dropping out of its top five holdings. Papa John's stock has underperformed the market, declining 30.7% over the past year while the S&P 500 gained 16.4%, amid struggling North American same-store sales.

02/22/2026, 10:08 AM • The Motley Fool

Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 Million

Warburg Pincus, a major shareholder and board member of Sotera Health, sold 9.7 million shares (22.18% of its indirect stake) for $158.7 million on December 3, 2025, at $16.33 per share. Despite the insider selling, Warburg Pincus retains over 34 million shares in the sterilization and lab services company, which has shown strong performance with 31.25% year-over-year growth and consistent earnings growth.

01/08/2026, 11:18 AM • The Motley Fool

Darsana Capital Opens New $189 Million Wingstop Position: Is the Stock a Buy?

Darsana Capital initiated a new $189 million stake in Wingstop, purchasing 750,000 shares representing 4.45% of their portfolio. Despite recent same-store sales declines, the investment suggests potential long-term growth in the restaurant chain.

11/18/2025, 12:36 PM • The Motley Fool

Peers

Statistics

More
Day Range
$15.40
$15.85
$15.57
1-Year Range
$10.94
$19.35
$15.57
Latest Close$15.57
Change
+$0.30 (+1.93%)
Volume2,778,116
Market Cap$4.5B
Shares Outstanding285.2M
P/E (TTM)38.16
Diluted EPS (TTM)$0.41
Enterprise Value$6.3B

Information as of 06/04/2026

Company Profile

SOTERA HEALTH CO
SOTERA HEALTH CO
https://soterahealth.com
$4.5B
Market Cap
$117.8M
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
9100 South Hills Blvd, Broadview Heights, OH, United States, 44147
440 262 1410

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Key Executives

  • Michael Petras Jr.
  • Jonathan Lyons
  • Michael Rutz
  • Sally R. Turner
  • Kristin A. Gibbs

Current Ownership Distribution

  • Institutions4.8B (90.35%)
  • Mutual Funds511.9M (9.58%)
  • Insiders4.0M (0.07%)
  • Other0 (0.00%)